Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
tepotinib | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Hepatic methionine adenosyltransferase deficiency[MeSHID:C564683] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
4.67 | approved | unknown |
tepotinib | hepatocyte growth factor receptor | small molecule | NA | drugbank , DGIDB | Hepatic methionine adenosyltransferase deficiency[MeSHID:C564683] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
4.67 | approved,investigational | inhibitor |
tepotinib | proto-oncogene c-met | NA | Successful target | TTD , DGIDB | Hepatic methionine adenosyltransferase deficiency[MeSHID:C564683] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
4.67 | approved | inhibitor |
tepotinib | melatonin receptor type 1b | small molecule | NA | drugbank | Hepatic methionine adenosyltransferase deficiency[MeSHID:C564683] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
NA | approved,investigational | inhibitor |
tepotinib | nischarin | small molecule | NA | drugbank | Hepatic methionine adenosyltransferase deficiency[MeSHID:C564683] epithelial to mesenchymal transition[MeSHID:D058750] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Liver carcinoma[MeSHID:D006528] |
NA | approved,investigational | inhibitor |
click here to return to the previous page |